I'm pretty sure two months is statistically insignificant in this context to even claim there are two months.
You'd need to explore the data behind the individual approvals to comment on statistical validity. But without going that deep, you can be assured that the FDA is generally pretty conservative, and employs very robust statistical methodology.
We don't know how many patients received the 72 drugs approved over a ten year period but we do know the potential customer base for the drugs is massive. Millions of people could have taken the drugs, you could easily get a statistically significant result.